ArticleMolecular therapy oncolytics2019

Bp-Bs, a Novel T-cell Engaging Bispecific Antibody with Biparatopic Her2 Binding, Has Potent Anti-tumor Activities.

Jiayu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.